Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (128)	10/18/1999 10:14:00 PM
From: jeffbas	Read Replies (1) \| Respond to of 438

Rick, as a future GZMO fund raising tool, down the road, would it appear that Japan Tobacco would be a good candidate to buy into the melanoma or breast cancer trials? Also, I can't understand the significance of the results reported in your recent Rosenberg references. Would you say the vaccine plus IL2 therapy work is showing good, bad or indifferent results based on the numbers given -- are we heading toward Phase III trials here or back to the drawing board?